中文
Notice On Notification of Drug Oversea Remote Inspection Results of Olmesartan Medoxomil and Amlodipine Besylate Tablets
Updated:2024-08-15

Aurobindo Pharma Limited,Aurovitas Pharma Taizhou Co., Ltd:


Please note that on August 12, 2024, CFDI sent the Notification of Drug Oversea Remote Inspection Results of Olmesartan Medoxomil and Amlodipine Besylate Tablets to the agency of the medicine in China.


If there are any questions, please do not hesitate to contact us as soon.


Contact: LI Shan


Tel.+86 10 68441670


Center for Food and Drug Inspection of NMPA    

August 13, 2024